Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Associations between Genomic Aberrations, Increased Nuchal Translucency, and Pregnancy Outcomes: A Comprehensive Analysis of 2,272 Singleton Pregnancies in Women Under 35

ABSTRACT: An investigation into a sub set of Fetus with increased nuchal translucency

INSTRUMENT(S): Illumina NextSeq 500

ORGANISM(S): Homo Sapiens

SUBMITTER: Henan Provincial People's Hospital

PROVIDER: PRJEB75654 | EVA | 2024-05-17

REPOSITORIES: EVA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	2024.05.09.final.CNVkit.cnv.vcf.csi	Other
	2024.05.09.final.CNVkit.cnv.vcf.gz	Vcf
	2024.05.09.final.CNVkit.cnv.vcf.gz.csi	Vcf

Items per page:

1 - 3 of 3

Similar Datasets

Comprehensive genomic analysis of relapse neuroblastoma [arrayCGH]

Project description:Relapse neuroblastoma were characterized by sequencing, gene expression, arrayCGH and genome-wide methylation. This data set contains the aCGH data.

2015-06-19 | GSE65304 | GEO

Comprehensive genomic analysis of relapse neuroblastoma [methylation]

Project description:Relapse neuroblastoma were characterized by sequencing, gene expression, arrayCGH and genome-wide methylation. This data set contains genome-wide methylation data.

2015-06-19 | GSE65306 | GEO

Investigation of cattle genetic variants

Project description:An investigation into a sub set of cattle genetic variantion

| PRJEB75603 | ENA

Comprehensive genomic analysis of relapse neuroblastoma [arrayCGH]

Project description:Relapse neuroblastoma were characterized by sequencing, gene expression, arrayCGH and genome-wide methylation. This data set contains the aCGH data. Array from tumours at relapse were compared to pretreatment tumours and corresponding normal samples.

2015-06-19 | E-GEOD-65304 | biostudies-arrayexpress

Comprehensive genomic analysis of relapse neuroblastoma [methylation]

Project description:Relapse neuroblastoma were characterized by sequencing, gene expression, arrayCGH and genome-wide methylation. This data set contains genome-wide methylation data. Array from tumours at relapse were compared to pretreatment tumours and corresponding normal samples.

2015-06-19 | E-GEOD-65306 | biostudies-arrayexpress

Genomic investigation of year long and multi-generational exposures of fathead minnow to the munitions compound RDX

Project description:This SuperSeries is composed of the following subset Series: GSE21100: One Year RDX Exposure, Liver Tissue Investigation GSE21101: One Year RDX Exposure, Brain Tissue Investigation GSE21102: Sub-adult RDX Exposure, Whole Body Tissue Investigation Refer to individual Series

2010-07-30 | E-GEOD-21103 | biostudies-arrayexpress

Development and validation of a genomic nomogram based on a ceRNA network for comprehensive analysis of obstructive sleep apnea

Project description:Some ceRNA associated with lncRNA have been considered as possible diagnostic and therapeutic biomarkers for obstructive sleep apnea (OSA). We intend to identify the potential hub genes for the development of OSA, which will provide a foundation for the study of the molecular mechanism underlying OSA and for the diagnosis and treatment of OSA.We collected plasma samples from OSA patients and healthy controls for the detection of ceRNA using a chip. Based on the differential expression of lncRNA, we identified the target genes of miRNA that bind to lncRNAs. We then constructed lncRNA-related ceRNA networks, performed functional enrichment analysis and protein-protein interaction analysis, and performed internal and external validation of the expression levels of stable hub genes. Then, we conducted LASSO regression analysis on the stable hub genes, selected relatively significant genes to construct a simple and easy-to-use nomogram, validated the nomogram, and constructed the core ceRNA sub-network of key genes.We successfully identified 282 DElncRNAs and 380 DEmRNAs through differential analysis, and we constructed an OSA-related ceRNA network consisting of 292 miRNA-lncRNAs and 41 miRNA-mRNAs. Through PPI and hub gene selection, we obtained 7 additional robust hub genes, CCND2, WT1, E2F2, IRF1, BAZ2A, LAMC1, and DAB2. Using LASSO regression analysis, we created a nomogram with four predictors (CCND2, WT1, E2F2, and IRF1), and its area under the curve (AUC) is 1. Finally, we constructed a core ceRNA sub-network composed of 74 miRNA-lncRNA and 7 miRNA-mRNA nodes.Our study provides a new foundation for elucidating the molecular mechanism of lncRNA in OSA and for diagnosing and treating OSA.

2023-04-25 | GSE226379 | GEO

Comprehensive analysis of circulating microRNAs in plasma of patients with pituitary adenomas

Project description:Background: Circulating miRNAs in pituitary adenoma would help patient care especially in non-functioning adenoma cases as minimally invasive biomarkers of tumor recurrence and progression. Aim: Our aim was to investigate plasma miRNA profile in patients with pituitary adenoma. Materials and Methods: 149 plasma and extracellular vesicle (preoperative, early- and late postoperative) samples were collected from 45 pituitary adenoma patients. Adenomas were characterized based on anterior pituitary hormones and transcription factors by immunostaining. MiRNA next generation sequencing was performed on 36 samples (discovery set). Individual TaqMan assay was used for validation on extended sample set. PA tissue miRNAs were evaluated by TaqMan array and literature data. Results: Global downregulation of miRNA expression was observed in plasma samples of pituitary adenoma patients compared to normal samples. Expression of 29 miRNAs and isomiR variants were able to distinguish preoperative plasma samples and normal controls. MiRNAs with altered expression in both plasma and different adenoma tissues were identified. 3, 7 and 66 miRNAs expressed differentially between preoperative and postoperative plasma samples in growth hormone secreting, FSH/LH+ and hormone-immunonegative groups, respectively. MiR-143-3p was downregulated in late- but not in early postoperative plasma samples compared to preoperative ones exclusively in FSH/LH+ adenomas. Plasma level of miR-143-3p discriminated these samples with 81.8% sensitivity and 72.3% specificity (AUC=0.79; p=0.02). Conclusions: Differentially expressed miRNAs in pituitary adenoma tissues have low abundance in plasma minimizing their role as biomarkers. Plasma miR-143-3p decreases in patients with FSH/LH+ adenoma indicated successful surgery, but its application for evaluating tumor recurrence needs further investigation.

2019-05-21 | GSE131483 | GEO

Genomic landscape of metastatic colorectal cancer

Project description:Response to drug therapy in individual colorectal cancer (CRC) patients is associated with tumor biology. Here we describe the genomic landscape of tumor samples of a homogeneous well-annotated series of patients with metastatic CRC of two phase III clinical trials, CAIRO and CAIRO2. DNA copy number aberrations of 349 patients are determined. Within three treatment arms, 194 chromosomal sub-regions are associated with progression free survival PFS (uncorrected single-test p-values < 0.005). These sub-regions are filtered for effect on mRNA expression, using an independent data set from The Cancer Genome Atlas (TCGA) which returned 171 genes. Three chromosomal regions are associated with a significant difference in PFS between treatment arms with or without irinotecan. One of these regions, 6q16.1-q21, correlates in vitro with sensitivity to SN-38, the active metabolite of irinotecan. This genomic landscape of metastatic CRC reveals a number of DNA copy number aberrations associated with response to drug therapy.

2014-11-14 | GSE36864 | GEO

Comprehensive genomic analysis of relapse neuroblastoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2015-06-19 | GSE65307 | GEO